Elpiscience Biopharmaceuticals Co., Limited Company Information

Current Status : Live


Elpiscience Biopharmaceuticals Co., Limited's Hong Kong CR Number is 2565665. Incorporation Date is 11-AUG-2017. It's Winding up Mode is . Dissolution date is None. Elpiscience Biopharmaceuticals Co., Limited company is of Private company limited by shares Type.
Additional Remarks on the Elpiscience Biopharmaceuticals Co., Limited company are .

Company Data

CRN2565665
Company NameElpiscience Biopharmaceuticals Co., Limited
Chinese NameNone
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation11-AUG-2017
See companies with same Incorporation Date - 11-AUG-2017
Date of DissolutionNone
Remarks
Important Note
Tagsco   biopharmaceuticals   elpiscience   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
Elpiscience Biopharmaceuticals Co., Limited11-AUG-2017

FAQs:

When was Elpiscience Biopharmaceuticals Co., Limited incorporated?

Elpiscience Biopharmaceuticals Co., Limited was incorporated on 11-AUG-2017 in Hongkong.

What is the type of Elpiscience Biopharmaceuticals Co., Limited?

Elpiscience Biopharmaceuticals Co., Limited is classified as Private company limited by shares.

What is the current status of Elpiscience Biopharmaceuticals Co., Limited Company?

The status of Elpiscience Biopharmaceuticals Co., Limited is Live.

What is the CR Number of Elpiscience Biopharmaceuticals Co., Limited?

The CR Number of Elpiscience Biopharmaceuticals Co., Limited is 2565665.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Elpiscience Biopharmaceuticals Co., Limited. The official registry should always be referred for latest information.

Last Updated on 18-08-2017.

Check other companies added on 18-08-2017

Check out Companies Incorporated on 11-AUG-2017: